Matches in Wikidata for { <http://www.wikidata.org/entity/Q89699857> ?p ?o ?g. }
- Q89699857 description "2020 nî lūn-bûn" @default.
- Q89699857 description "2020年の論文" @default.
- Q89699857 description "2020年学术文章" @default.
- Q89699857 description "2020年学术文章" @default.
- Q89699857 description "2020年学术文章" @default.
- Q89699857 description "2020年学术文章" @default.
- Q89699857 description "2020年学术文章" @default.
- Q89699857 description "2020年学术文章" @default.
- Q89699857 description "2020年學術文章" @default.
- Q89699857 description "2020年學術文章" @default.
- Q89699857 description "2020年學術文章" @default.
- Q89699857 description "2020年學術文章" @default.
- Q89699857 description "2020年學術文章" @default.
- Q89699857 description "2020년 논문" @default.
- Q89699857 description "article científic" @default.
- Q89699857 description "article scientific" @default.
- Q89699857 description "article scientifique" @default.
- Q89699857 description "articol științific" @default.
- Q89699857 description "articolo scientifico" @default.
- Q89699857 description "artigo científico" @default.
- Q89699857 description "artigo científico" @default.
- Q89699857 description "artigo científico" @default.
- Q89699857 description "artikel ilmiah" @default.
- Q89699857 description "artikull shkencor" @default.
- Q89699857 description "artikulong pang-agham" @default.
- Q89699857 description "artykuł naukowy" @default.
- Q89699857 description "artículo científico publicado en 2020" @default.
- Q89699857 description "artículu científicu" @default.
- Q89699857 description "bilimsel makale" @default.
- Q89699857 description "bài báo khoa học" @default.
- Q89699857 description "naučni članak" @default.
- Q89699857 description "scienca artikolo" @default.
- Q89699857 description "scientific article published on 13 February 2020" @default.
- Q89699857 description "scientific article published on 13 February 2020" @default.
- Q89699857 description "scientific article published on 13 February 2020" @default.
- Q89699857 description "teaduslik artikkel" @default.
- Q89699857 description "tieteellinen artikkeli" @default.
- Q89699857 description "tudományos cikk" @default.
- Q89699857 description "vedecký článok" @default.
- Q89699857 description "vetenskaplig artikel" @default.
- Q89699857 description "videnskabelig artikel udgivet 13. februar 2020" @default.
- Q89699857 description "vitenskapelig artikkel" @default.
- Q89699857 description "vitskapeleg artikkel" @default.
- Q89699857 description "vědecký článek" @default.
- Q89699857 description "wetenschappelijk artikel" @default.
- Q89699857 description "wissenschaftlicher Artikel" @default.
- Q89699857 description "επιστημονικό άρθρο" @default.
- Q89699857 description "мақолаи илмӣ" @default.
- Q89699857 description "наукова стаття, опублікована в лютому 2020" @default.
- Q89699857 description "научна статия" @default.
- Q89699857 description "научная статья" @default.
- Q89699857 description "научни чланак" @default.
- Q89699857 description "научни чланак" @default.
- Q89699857 description "գիտական հոդված հրատարակված 2020 թվականի փետրվարի 13-ին" @default.
- Q89699857 description "מאמר מדעי" @default.
- Q89699857 description "مقالة علمية نشرت في 13 فبراير 2020" @default.
- Q89699857 description "১৩ ফেব্রুয়ারি ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q89699857 description "บทความทางวิทยาศาสตร์" @default.
- Q89699857 description "სამეცნიერო სტატია" @default.
- Q89699857 name "Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF)" @default.
- Q89699857 name "Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF)" @default.
- Q89699857 type Item @default.
- Q89699857 label "Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF)" @default.
- Q89699857 label "Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF)" @default.
- Q89699857 prefLabel "Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF)" @default.
- Q89699857 prefLabel "Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF)" @default.
- Q89699857 P1433 Q89699857-9433E36F-B32A-42D3-8F15-82A720C67C21 @default.
- Q89699857 P1476 Q89699857-885B5DA3-E3D1-4D22-928D-03758BFBA061 @default.
- Q89699857 P2093 Q89699857-00259B39-CCFD-4976-B179-4EB94C6E62D3 @default.
- Q89699857 P2093 Q89699857-0B71E123-EB7F-4632-86E6-844DCEB237D3 @default.
- Q89699857 P2093 Q89699857-223679E8-2212-4644-B5E8-4B66B5BDAD77 @default.
- Q89699857 P2093 Q89699857-451E31AD-88FA-4919-9201-CB147DC1A205 @default.
- Q89699857 P2093 Q89699857-5069A6CF-F613-480D-A684-AD904B16F065 @default.
- Q89699857 P2093 Q89699857-80B01D86-BDE5-4037-A87D-BB77686A0502 @default.
- Q89699857 P2093 Q89699857-9BAB69CB-5680-461C-9E39-7436D90149C6 @default.
- Q89699857 P2860 Q89699857-18B74BE7-D8E5-40CA-AE7F-50275815C51C @default.
- Q89699857 P2860 Q89699857-19A384B7-7CF7-49B3-A2CB-34B3D4F8BBAD @default.
- Q89699857 P2860 Q89699857-2C06C1EA-0BA0-4D0B-9822-0CC8730418FB @default.
- Q89699857 P2860 Q89699857-5A7BEA04-1BDD-4653-ADB6-86B314D16C38 @default.
- Q89699857 P2860 Q89699857-80A67247-7572-4D76-9FC4-AF2E9F6B1ACE @default.
- Q89699857 P2860 Q89699857-8C5954D8-5E71-4125-839D-CF9A0B926FFE @default.
- Q89699857 P2860 Q89699857-96FB801D-3FB5-4112-807A-AA30DBDF36AB @default.
- Q89699857 P2860 Q89699857-AAE2DFBA-54A7-40B8-B2DC-DDA979B962CD @default.
- Q89699857 P2860 Q89699857-BAD9F79A-2B12-4013-8656-ADC9899CED64 @default.
- Q89699857 P2860 Q89699857-CF8D8792-7F5F-4BB8-9CC4-94F8078453FE @default.
- Q89699857 P2860 Q89699857-D74E0310-3FB8-4E83-9811-2401557ED888 @default.
- Q89699857 P2860 Q89699857-D82407AE-DE7D-4455-B160-DA94A4B13A6A @default.
- Q89699857 P304 Q89699857-17978F3A-BC2C-4DDB-B3E5-77B1E304BAC0 @default.
- Q89699857 P31 Q89699857-6C4C02B1-2E15-46FA-983D-FC29A70BEEBD @default.
- Q89699857 P356 Q89699857-18B19DFE-FCAB-483C-BB14-85DC9BD0A881 @default.
- Q89699857 P433 Q89699857-B3A330E1-0BAD-42E7-B55D-F241D6BF8BB4 @default.
- Q89699857 P478 Q89699857-B17AEF91-4CC6-44C9-851F-3B9DAD37863C @default.
- Q89699857 P50 Q89699857-516DDAD5-3258-46D3-9A7B-4B7511447089 @default.
- Q89699857 P50 Q89699857-B3FE3DF9-BC8E-4FBE-BCEB-FE9A40916B9D @default.
- Q89699857 P577 Q89699857-9EFAAA11-1846-4016-87B6-A685C3C4663E @default.
- Q89699857 P698 Q89699857-27FF6BA1-C148-420E-A759-F0E9F74FC7EF @default.
- Q89699857 P921 Q89699857-549C9944-4231-4541-A8CC-BAF5931EEC3E @default.
- Q89699857 P921 Q89699857-880A1100-3D00-45BD-B703-6065F3B83A60 @default.
- Q89699857 P921 Q89699857-9939D7A2-D718-43B2-A522-BE61FA514537 @default.
- Q89699857 P921 Q89699857-E53911B8-2975-441D-BF64-3BBD4E217359 @default.